On June 10, 2023 at Lincoln Financial Field, more than 700 local philanthropists, corporate leaders and patient families came together for the hospital’s signature fundraiser, the Carousel Ball, raising more than $4.1 million for autism research and care at CHOP.

Summer provides more opportunities for kids to be active and enjoy the outdoors. Unfortunately, it also means more injuries.

Researchers from the Minds Matter Concussion Program at Children’s Hospital of Philadelphia have extensively researched the use of visio-vestibular examinations (VVEs) to improve concussion diagnosis in care. Now, that research is at the heart of new best practice recommendations made by a panel of more than 100 leading concussion experts around the world.

This award honors a CHOP employee who has gone above and beyond to make an impact on the lives of children treated in the Division of Oncology.

CHOP researchers have found that self-esteem in short youth is associated with coping skills and how supported they feel and not the degree of their short stature. 

CHOP researchers have identified a molecule that plays a role in post-translational modification and activation in myeloid cancers, making it a potential therapeutic target.

Earlier this month, Children’s Hospital of Philadelphia (CHOP) was excited to host the annual Joshua Kahan Fund Prom at CHOP for patients and their families.

You might be feeling anxious about the poor air quality in our region. While this problem is real, it does not mean that there is nothing we can do to help keep our family safe.

Researchers from Children’s Hospital of Philadelphia (CHOP) confirmed that “mini-intestines” generated from patient tissue samples and grown in a lab can accurately replicate certain features of Crohn’s disease, which will allow them to study the epithelium, the thin layer of cells lining the intestine, that is broken down in patients with inflammatory bowel disease. 

CHOP researchers have engineered stable, universal MHC-I molecules that can be produced rapidly at scale, allowing researchers to develop vaccines and immunotherapies more quickly.